If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,865.00
Bid: 4,860.00
Ask: 4,863.00
Change: -12.00 (-0.25%)
Spread: 3.00 (0.062%)
Open: 4,892.00
High: 4,910.00
Low: 4,857.00
Prev. Close: 4,877.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

25 Apr 2019 09:53

RNS Number : 0854X
Croda International PLC
25 April 2019
 

Croda International Plc - Annual General Meeting

 

The ninety-fourth Annual General Meeting of Croda International Plc (the "Company") was held at the Pavilions of Harrogate, Great Yorkshire Showground, North Yorkshire HG2 8QZ on Wednesday 24 April 2019.

 

All of the resolutions were voted upon by poll and were passed by shareholders. The total number of ordinary shares in issue: 131,794,934 (excluding shares held in treasury).

 

The results of the poll for each resolution are as follows:

 

Resolution

Votes For

Against

Withheld

No of shares

% of shares voted

No of shares

% of shares voted

 

No of shares

1. To receive the financial statements of the Company and the Group and the reports of the directors and auditors for the year ended 31 December 2018

96,800,460

99.997

3,306

0.003

266,520

2. To approve the Directors' Remuneration Report for the year ended 31 December 2015, in accordance with section 439 of the Companies Act 2006

85,949,463

88.70

10,947,479

11.30

173,343

3. To declare a final dividend of 49 pence per ordinary share

96,037,710

99.10

867,966

0.90

164,610

4. To elect R Cirillo as a director

95,776,221

98.84

1,121,080

1.16

172,784

5. To re-elect A M Ferguson as a director

94,597,964

97.63

2,300,415

2.37

171,706

6. To elect J P C Ferguson as a director

96,455,932

99.54

441,473

0.46

172,680

7. To re-elect S E Foots as a director

95,894,318

98.96

1,004,782

1.04

170,985

8. To re-elect A M Frew as a director

94,025,926

97.46

2,446,009

2.54

598,148

9. To re-elect H L Ganczakowski as a director

95,384,598

98.45

1,506,147

1.55

179,339

10. To re-elect K Layden as a director

94,257,481

97.27

2,641,538

2.73

171,066

11. To re-elect J K Maiden as a director

95,684,691

98.75

1,213,303

1.25

172,091

12. To re-appoint KPMG LLP as auditors of the Company

96,108,998

99.18

795,780

0.82

165,508

13. To authorise the Audit Committee to determine the auditors' remuneration

96,082,647

99.15

821,699

0.85

165,940

14. Political donations

94,958,604

98.51

1,434,774

1.49

676,908

15. To authorise the directors to allot relevant securities up to two thirds of its issued share capital

89,241,778

92.09

7,661,715

7.91

166,793

16. To authorise the directors to allot equity securities without pre-emptive rights up to an aggregate nominal amount of £682,510

95,069,419

98.38

1,567,758

1.62

433,109

17. To authorise the directors to allot equity securities without pre-emptive rights up to an additional aggregate nominal amount of £682,510

95,182,546

98.50

1,453,548

1.50

434,191

18. To authorise market purchase of own shares up to a maximum of 12,865,697 ordinary shares

96,450,317

99.57

418,135

0.43

201,833

19. That a general meeting (other than an annual general meeting) may be called on not less than 14 clear days' notice

88,215,218

91.44

8,259,154

8.56

595,914

20. To declare a special dividend of 115 pence per ordinary share and associated share consolidation

96,788,283

99.88

116,361

0.12

166,442

 

Resolutions 1 to 15 (inclusive) were passed as ordinary resolutions and resolutions 16 to 20 (inclusive) were passed as special resolutions. The full text of the resolutions is set out in the Notice of Annual General Meeting, a copy of which is on the Company's website (investor centre) and has also been made available for inspection through the National Storage Mechanism which can be found at http://www.morningstar.co.uk/uk/NSM.

Share Consolidation 

The Share Consolidation is due to take effect upon admission of the New Ordinary Shares of 10.609756 pence each in the capital of the Company to the premium segment of the Official List and to trading on the London Stock Exchange's main market, expected to be at 8.00am on Monday 29 April 2019. As a result of the Share Consolidation shareholders will hold 41 New Ordinary Shares of 10.609756 pence each for every 42 Existing Ordinary Shares of 10.357143 pence each held at close of business on 26 April 2019.

Accordingly, application has been made to the UK Listing Authority ("UKLA") for 131,906,881 New Ordinary Shares of 10.609756 pence each (of which 3,249,906 will be held in treasury) to be admitted to the premium listing segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities. The New Ordinary Shares will have an ISIN of GB00BJFFLV09.

The Special Dividend of 115 pence per existing Ordinary Share, which was announced on 26 February 2019 and was conditional upon the Share Consolidation being approved, will be paid on 30 May 2019 to shareholders on the register at close of business on 26 April 2019 (with an ex-entitlement date of 29 April 2019).

 

Issue of Ordinary Shares and Cancellation of Treasury Shares

 

In order to ensure that the number of existing ordinary shares of the Company is exactly divisible by 42, the Company intends to issue 16 ordinary shares of 10.357143 pence each to the Croda International Plc Employee Benefit Trust and to cancel 2 ordinary shares held in treasury.

 

An application has been made for the 16 ordinary shares to be admitted to the premium listing segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities. Admission is expected to become effective at 8.00am UK time on 26 April 2019. The 16 ordinary shares will form part of the share consolidation described above.

 

Following the admission of the 16 ordinary shares, which is anticipated to take place at 8.00am UK time on 26 April 2019, and the cancellation of the 2 ordinary shares held in treasury, the Company will, until the share consolidation becomes effective on 29 April, have 135,124,122 ordinary shares of 10.357143 pence each in issue, of which 3,329,172 shares will be held in treasury.

 

Below is an expected timetable of for the Share Consolidation and Special Dividend:

 

Ex dividend date for final dividend

Thursday 11 April 2019

Record date for final dividend

Close of business on Friday 12 April 2019

Annual General Meeting

12 noon on Wednesday 24 April 2019

Record date for special dividend and share consolidation

Close of business on Friday 26 April 2019

Last day for dealing in Existing Ordinary Shares

Friday 26 April 2019

Ex-dividend date for special dividend

Monday 29 April 2019

Commencement of dealings in New Ordinary Shares

8.00am on Monday 29 April 2019

CREST accounts credited with new ordinary shares

As soon as possible after 8.00am on Monday 29 April 2019

Latest time and date for election to participate in DRIP for final dividend

5.00pm on Tuesday 30 April 2019

Latest time and date for election to participate in DRIP for special dividend

5.00pm on Monday 13 May 2019

Despatch of cheques for fractional entitlements for New Ordinary Shares; despatch of certificates of New Ordinary Shares; CREST accounts credited with value of fractional entitlements (in each case where applicable)

By Friday 17 May 2019

Payment date for final dividend and special dividend

Thursday 30 May 2019

Purchase of New Ordinary Shares for DRIP participants with respect to final and special dividend will commence on

Thursday 30 May 2019

Despatch of share certificates and crediting of CREST accounts in relation to DRIP purchases

On or after 3 June 2019

 

 

Tom Brophy

Group General Counsel & Company Secretary

 

25 April 2019

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGCKPDQFBKKCQB
Date   Source Headline
2nd May 20249:27 amRNSDirector/PDMR Shareholding
1st May 202412:18 pmRNSDirector/PDMR Shareholding
25th Apr 202410:01 amRNSResult of AGM
24th Apr 20247:00 amRNSFirst quarter 2024 sales update
11th Apr 20242:11 pmRNSDirector/PDMR Shareholding
8th Apr 202410:54 amRNSDirector/PDMR Shareholding
8th Apr 202410:23 amRNSDirector/PDMR Shareholding
28th Mar 20249:17 amRNSDirector/PDMR Shareholding
26th Mar 20244:19 pmRNSDirector/PDMR Shareholding
26th Mar 20244:10 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSDirector/PDMR Shareholding
26th Mar 20244:06 pmRNSDirector/PDMR Shareholding
26th Mar 20244:04 pmRNSDirector/PDMR Shareholding
15th Mar 20249:32 amRNSAnnual Financial Report
12th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20243:03 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
9th Feb 20243:28 pmRNSHolding(s) in Company
18th Jan 20241:33 pmRNSHolding(s) in Company
11th Jan 20243:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20233:08 pmRNSDirector/PDMR Shareholding
11th Dec 202311:39 amRNSDirector Declaration
29th Nov 20234:54 pmRNSHolding(s) in Company
28th Nov 20239:35 amRNSDirector/PDMR Shareholding
24th Nov 202311:33 amRNSHolding(s) in Company
14th Nov 20239:40 amRNSDirector/PDMR Shareholding
19th Oct 202311:19 amRNSHolding(s) in Company
19th Oct 202310:34 amRNSDirector/PDMR Shareholding
12th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSThird Quarter Trading Update
6th Oct 20234:12 pmRNSDirector/PDMR Shareholding
5th Oct 20238:53 amRNSHolding(s) in Company
3rd Oct 20234:03 pmRNSDirector/PDMR Shareholding
27th Sep 20235:17 pmRNSDirector/PDMR Shareholding
26th Sep 202311:38 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirectorate Change
15th Sep 202311:51 amRNSDirector/PDMR Shareholding
12th Sep 20234:01 pmRNSDirector/PDMR Shareholding
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding
1st Aug 20237:13 amRNSDirector Declaration
25th Jul 20237:00 amRNSResults for the six months ended 30 June 2023
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
4th Jul 20238:02 amRNSCroda completes acquisition of Solus Biotech
26th Jun 202310:46 amRNSHolding(s) in Company
13th Jun 20233:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.